Xingqiao Wen

1.4k total citations
41 papers, 1.0k citations indexed

About

Xingqiao Wen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Xingqiao Wen has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Xingqiao Wen's work include Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Pediatric Urology and Nephrology Studies (6 papers). Xingqiao Wen is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Pediatric Urology and Nephrology Studies (6 papers). Xingqiao Wen collaborates with scholars based in China, United States and Canada. Xingqiao Wen's co-authors include Xin Gao, Xiaojuan Li, Hengjun Xiao, Weixin Yan, Jun Wang, Fátima Carneiro, Zheng Chen, Jun Chen, Shuyuan Yeh and Defeng Xu and has published in prestigious journals such as Advanced Functional Materials, Cancer Research and Gut.

In The Last Decade

Xingqiao Wen

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingqiao Wen China 16 449 295 271 216 200 41 1.0k
Qifei Wu China 19 522 1.2× 167 0.6× 182 0.7× 210 1.0× 82 0.4× 60 1.1k
Carmela Coppola Italy 25 437 1.0× 193 0.7× 149 0.5× 257 1.2× 109 0.5× 52 1.4k
Hyunho Yoon South Korea 16 569 1.3× 111 0.4× 277 1.0× 101 0.5× 86 0.4× 30 1.1k
Yinghao Sun China 16 556 1.2× 484 1.6× 178 0.7× 93 0.4× 63 0.3× 30 1.4k
Beatrice Faraglia Italy 18 601 1.3× 151 0.5× 230 0.8× 201 0.9× 116 0.6× 22 1.1k
Rui Ling China 18 638 1.4× 129 0.4× 395 1.5× 90 0.4× 89 0.4× 63 1.1k
Muxing Kang China 19 579 1.3× 140 0.5× 272 1.0× 189 0.9× 70 0.3× 33 1.1k
Claudio Pulito Italy 21 785 1.7× 286 1.0× 525 1.9× 115 0.5× 55 0.3× 36 1.3k
Loris Bertazza Italy 21 373 0.8× 97 0.3× 256 0.9× 140 0.6× 112 0.6× 60 1.1k
Ruipeng Song China 22 997 2.2× 145 0.5× 651 2.4× 178 0.8× 174 0.9× 51 1.7k

Countries citing papers authored by Xingqiao Wen

Since Specialization
Citations

This map shows the geographic impact of Xingqiao Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingqiao Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingqiao Wen more than expected).

Fields of papers citing papers by Xingqiao Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingqiao Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingqiao Wen. The network helps show where Xingqiao Wen may publish in the future.

Co-authorship network of co-authors of Xingqiao Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Xingqiao Wen. A scholar is included among the top collaborators of Xingqiao Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingqiao Wen. Xingqiao Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wanjing, et al.. (2025). Lipophagy suppression: a novel mechanism for developmental disruption by nanoplastics/MC-LR in zebrafish. Environment International. 207. 110004–110004.
2.
Li, Xiaojuan, et al.. (2024). HJURP inhibits sensitivity to ferroptosis inducers in prostate cancer cells by enhancing the peroxidase activity of PRDX1. Redox Biology. 77. 103392–103392. 8 indexed citations
3.
Huang, Shuang, Chuanjie Yao, Xinshuo Huang, et al.. (2023). Petromyzontidae‐Biomimetic Multimodal Microneedles‐Integrated Bioelectronic Catheters for Theranostic Endoscopic Surgery. Advanced Functional Materials. 33(15). 13 indexed citations
4.
Wen, Xingqiao, et al.. (2022). Survival Analysis and a Novel Nomogram Model for Progression-Free Survival in Patients with Prostate Cancer. Journal of Oncology. 2022. 1–14. 2 indexed citations
5.
Wu, Tingting, Keying Chen, Xingqiao Wen, et al.. (2022). Bovine serum albumin-gold nanoclusters protein corona stabilized polystyrene nanoparticles as dual-color fluorescent nanoprobes for breast cancer detection. Biosensors and Bioelectronics. 215. 114575–114575. 17 indexed citations
6.
Wainberg, Zev A., Ignacio Matos, Jean‐Pierre Delord, et al.. (2021). LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer. Annals of Oncology. 32. S227–S228. 15 indexed citations
7.
Wang, Yu, Chutian Xiao, Xiaopeng Liu, et al.. (2021). 68Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy. Asian Journal of Andrology. 24(1). 97–101. 3 indexed citations
8.
Wen, Xingqiao, et al.. (2020). Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?. Annals of Surgical Oncology. 27(11). 4204–4215. 5 indexed citations
9.
NISHIO, MAKI, Fabrice Barlési, S. Ball, et al.. (2020). 375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC. Annals of Oncology. 31. S1386–S1387. 9 indexed citations
10.
Li, Xiaojuan, et al.. (2020). GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway. Laboratory Investigation. 101(5). 554–563. 23 indexed citations
11.
Wang, Yu, Xingqiao Wen, Chutian Xiao, et al.. (2019). Comparative study of fluorescence vs. high-definition laparoscopy in extended pelvic lymph node dissection plus radical prostatectomy for patients with locally advanced prostate cancer. Zhonghua miniao waike zazhi. 40(3). 161–166. 1 indexed citations
12.
Li, Xiaojuan, Jun Li, Yi Cai, et al.. (2018). Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer. Cancer Letters. 418. 211–220. 40 indexed citations
13.
Xiao, Hengjun, Jun Wang, Weixin Yan, et al.. (2017). GLUT1 regulates cell glycolysis and proliferation in prostate cancer. The Prostate. 78(2). 86–94. 125 indexed citations
15.
Wang, Jun, Jitong Li, Xiaojuan Li, et al.. (2017). Increased expression of glycolytic enzymes in prostate cancer tissues and association with Gleason scores.. PubMed. 10(11). 11080–11089. 6 indexed citations
16.
Zhu, Baoyi, et al.. (2011). Morphological and genetic changes in the prostate of rats with diabetes. Zhonghua shiyan waike zazhi. 28(9). 1535–1538. 1 indexed citations
17.
Worthley, Daniel L., Kerry Phillips, Kasmintan A. Schrader, et al.. (2011). Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 61(5). 774–779. 171 indexed citations
18.
Xu, Defeng, Tzu‐Hua Lin, Shaoshun Li, et al.. (2011). Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. Cancer Letters. 316(1). 11–22. 64 indexed citations
19.
Wen, Xingqiao, Xiaojuan Li, Bing Liao, et al.. (2009). Knockdown of p21-activated Kinase 6 Inhibits Prostate Cancer Growth and Enhances Chemosensitivity to Docetaxel. Urology. 73(6). 1407–1411. 40 indexed citations
20.
Wen, Xingqiao. (2006). Effects of dendritic cells co-cultured with CIK cells on renal carcinoma cells. Zhongguo bingli shengli zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026